Person A/Pr Susan Branford National Health and Medical Research Council Viewed: [[ro.stat.viewed]] Click to explore relationships graph Help Related Grants and Projects Principal investigator of Assessment of markers of genomic instability for the prediction of treatment response in chronic myeloid leukaemia (funded by National Health and Medical Research Council) Participant in Chronic Myeloid Leukaemia: Changing the treatment paradigm (funded by National Health and Medical Research Council) Principal investigator of Defining genomic mechanisms associated with treatment response, drug resistance and early blast crisis in chronic myeloid leukaemia (funded by National Health and Medical Research Council) Participant in Determining the prerequisites for the achievement of treatment-free remission in chronic myeloid leukaemia to facilitate the development of new therapeutic approaches with curative intent (funded by National Health and Medical Research Council) Participant in Development and assessment of novel assays to predict response to second-line TKI therapy in imatinib-resistant CML (funded by National Health and Medical Research Council) User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover Saved to MyRDA Save to MyRDA
Click to explore relationships graph Help Related Grants and Projects Principal investigator of Assessment of markers of genomic instability for the prediction of treatment response in chronic myeloid leukaemia (funded by National Health and Medical Research Council) Participant in Chronic Myeloid Leukaemia: Changing the treatment paradigm (funded by National Health and Medical Research Council) Principal investigator of Defining genomic mechanisms associated with treatment response, drug resistance and early blast crisis in chronic myeloid leukaemia (funded by National Health and Medical Research Council) Participant in Determining the prerequisites for the achievement of treatment-free remission in chronic myeloid leukaemia to facilitate the development of new therapeutic approaches with curative intent (funded by National Health and Medical Research Council) Participant in Development and assessment of novel assays to predict response to second-line TKI therapy in imatinib-resistant CML (funded by National Health and Medical Research Council) User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover
